Literature DB >> 22528093

Search for amyloid-binding proteins by affinity chromatography.

Miguel Calero1, Agueda Rostagno, Jorge Ghiso.   

Abstract

'Amyloid binging proteins' is a generic term used to designate proteins that interact with different forms of amyloidogenic peptides or proteins and that, as a result, may modulate their physiological and pathological functions by altering solubility, transport, clearance, degradation, and fibril formation. We describe a simple affinity chromatography protocol to isolate and characterize amyloid-binding proteins based on the use of sequential elution steps that may provide further information on the type of binding interaction. As an example, we depict the application of this protocol to the study of Alzheimer's amyloid β (Aβ) peptide-binding proteins derived from human plasma. Biochemical analysis of the proteins eluted under different conditions identified serum amyloid P component (SAP) and apolipoprotein J (clusterin) as the main plasma Aβ-binding proteins while various apolipoproteins (apoA-IV, apoE, and apoA-I), as well as albumin (HSA) and fibulin were identified as minor contributors.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22528093      PMCID: PMC3665336          DOI: 10.1007/978-1-61779-551-0_15

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  35 in total

Review 1.  Affinity chromatography: general methods.

Authors:  Marjeta Urh; Dan Simpson; Kate Zhao
Journal:  Methods Enzymol       Date:  2009       Impact factor: 1.600

2.  Isolation and characterization of amyloid P component from Alzheimer's disease and other types of cerebral amyloidosis.

Authors:  F Coria; E Castaño; F Prelli; M Larrondo-Lillo; S van Duinen; M L Shelanski; B Frangione
Journal:  Lab Invest       Date:  1988-04       Impact factor: 5.662

3.  Differences between vascular and plaque core amyloid in Alzheimer's disease.

Authors:  F Prelli; E Castaño; G G Glenner; B Frangione
Journal:  J Neurochem       Date:  1988-08       Impact factor: 5.372

4.  Nonamyloidotic monoclonal immunoglobulin deposits lack amyloid P component.

Authors:  G Gallo; M Picken; B Frangione; J Buxbaum
Journal:  Mod Pathol       Date:  1988-11       Impact factor: 7.842

5.  Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein.

Authors:  G G Glenner; C W Wong
Journal:  Biochem Biophys Res Commun       Date:  1984-05-16       Impact factor: 3.575

6.  Proteomic analysis of exfoliation deposits.

Authors:  Boris Ovodenko; Agueda Rostagno; Thomas A Neubert; Vivekananda Shetty; Stefani Thomas; Austin Yang; Jeffrey Liebmann; Jorge Ghiso; Robert Ritch
Journal:  Invest Ophthalmol Vis Sci       Date:  2007-04       Impact factor: 4.799

7.  Apolipoprotein E immunoreactivity in cerebral amyloid deposits and neurofibrillary tangles in Alzheimer's disease and kuru plaque amyloid in Creutzfeldt-Jakob disease.

Authors:  Y Namba; M Tomonaga; H Kawasaki; E Otomo; K Ikeda
Journal:  Brain Res       Date:  1991-02-08       Impact factor: 3.252

8.  Targeting of cell-surface beta-amyloid precursor protein to lysosomes: alternative processing into amyloid-bearing fragments.

Authors:  C Haass; E H Koo; A Mellon; A Y Hung; D J Selkoe
Journal:  Nature       Date:  1992-06-11       Impact factor: 49.962

9.  Widespread serum amyloid P immunoreactivity in cortical amyloid deposits and the neurofibrillary pathology of Alzheimer's disease and other degenerative disorders.

Authors:  R N Kalaria; P G Galloway; G Perry
Journal:  Neuropathol Appl Neurobiol       Date:  1991-06       Impact factor: 8.090

10.  Neuronal origin of a cerebral amyloid: neurofibrillary tangles of Alzheimer's disease contain the same protein as the amyloid of plaque cores and blood vessels.

Authors:  C L Masters; G Multhaup; G Simms; J Pottgiesser; R N Martins; K Beyreuther
Journal:  EMBO J       Date:  1985-11       Impact factor: 11.598

View more
  11 in total

1.  Aβ truncated species: Implications for brain clearance mechanisms and amyloid plaque deposition.

Authors:  Erwin Cabrera; Paul Mathews; Emiliya Mezhericher; Thomas G Beach; Jingjing Deng; Thomas A Neubert; Agueda Rostagno; Jorge Ghiso
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2017-07-13       Impact factor: 5.187

2.  Sequential Amyloid-β Degradation by the Matrix Metalloproteases MMP-2 and MMP-9.

Authors:  Mar Hernandez-Guillamon; Stephanie Mawhirt; Steven Blais; Joan Montaner; Thomas A Neubert; Agueda Rostagno; Jorge Ghiso
Journal:  J Biol Chem       Date:  2015-04-20       Impact factor: 5.157

Review 3.  Pathophysiology and treatment of systemic amyloidosis.

Authors:  Julian D Gillmore; Philip N Hawkins
Journal:  Nat Rev Nephrol       Date:  2013-08-27       Impact factor: 28.314

Review 4.  Amyloid-clearing proteins and their epigenetic regulation as a therapeutic target in Alzheimer's disease.

Authors:  Natalia N Nalivaeva; Nikolai D Belyaev; Caroline Kerridge; Anthony J Turner
Journal:  Front Aging Neurosci       Date:  2014-09-17       Impact factor: 5.750

5.  The effects of endogenous non-peptide molecule isatin and hydrogen peroxide on proteomic profiling of rat brain amyloid-β binding proteins: relevance to Alzheimer's disease?

Authors:  Alexei E Medvedev; Olga A Buneeva; Arthur T Kopylov; Oksana V Gnedenko; Marina V Medvedeva; Sergey A Kozin; Alexis S Ivanov; Victor G Zgoda; Alexander A Makarov
Journal:  Int J Mol Sci       Date:  2014-12-29       Impact factor: 5.923

6.  The amyloid interactome: Exploring protein aggregation.

Authors:  Konstantina V Biza; Katerina C Nastou; Paraskevi L Tsiolaki; Chara V Mastrokalou; Stavros J Hamodrakas; Vassiliki A Iconomidou
Journal:  PLoS One       Date:  2017-03-01       Impact factor: 3.240

Review 7.  Extracellular protein components of amyloid plaques and their roles in Alzheimer's disease pathology.

Authors:  M Mahafuzur Rahman; Christofer Lendel
Journal:  Mol Neurodegener       Date:  2021-08-28       Impact factor: 14.195

8.  Association of clusterin with the BRI2-derived amyloid molecules ABri and ADan.

Authors:  Agueda Rostagno; Miguel Calero; Janice L Holton; Tamas Revesz; Tammaryn Lashley; Jorge Ghiso
Journal:  Neurobiol Dis       Date:  2021-07-21       Impact factor: 7.046

9.  Mechanisms of action of therapeutic amyloidogenic hexapeptides in amelioration of inflammatory brain disease.

Authors:  Michael P Kurnellas; Jill M Schartner; C Garrison Fathman; Ann Jagger; Lawrence Steinman; Jonathan B Rothbard
Journal:  J Exp Med       Date:  2014-07-29       Impact factor: 14.307

10.  Direct High Affinity Interaction between Aβ42 and GSK3α Stimulates Hyperphosphorylation of Tau. A New Molecular Link in Alzheimer's Disease?

Authors:  Christopher J Dunning; Gavin McGauran; Katarina Willén; Gunnar K Gouras; David J O'Connell; Sara Linse
Journal:  ACS Chem Neurosci       Date:  2015-12-15       Impact factor: 4.418

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.